Carregant...
Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the fifth most common cancer, and its incidence is rapidly increasing in North America and Western Europe as well as South-East Asia. Patients with advanced stage HCC have very poor outcomes; therefore, the discovery of new innovative approaches is urgently needed....
Guardat en:
| Publicat a: | World J Gastroenterol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Baishideng Publishing Group Inc
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6543238/ https://ncbi.nlm.nih.gov/pubmed/31171886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v25.i20.2416 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|